6 Sep 2016 07:00
Â
Â
("NetScientific" or the "Company" or the "Group")
Â
Â
Notice of Interim Results
Â
Â
London, UK - 6 September 2016 - NetScientific plc ("NetScientific", AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces that it will report its interim results for the six months ended 30 June 2016 on Tuesday 27 September2016.
Â
An analyst presentation will be held at the offices of Stifel Nicholaus Europe at 150 Cheapside, London EC2V 6ET at 12.00pm on Tuesday 27 September 2016.
Â
- Ends -
Â
Â
For more information, please contact:
Â
NetScientific François R. Martelet, M.D., CEO Ian Postlethwaite, CFO  | Tel: +44 (0)20 3514 1800 |
Stifel Nicolaus Europe Limited (NOMAD and broker) Jonathan Senior / David Arch / Ben Maddison | Tel: +44 (0)20 7710 7600 |
 Consilium Strategic Communications Mary-Jane Elliott / Chris Gardner / Jessica Hodgson / Chris Welsh / Laura Thornton  |  Tel: +44 (0)20 3709 5700 netscientific@consilium-comms.com |
Â
Â
About NetScientific Plc
Â
NetScientific is a transatlantic healthcare technology group with an investment strategy focused on sourcing, funding and commercialising technologies that significantly improve the health and well-being of people with chronic diseases. For more information, please visit the website at www.netscientific.net.